Article

Cole National sells Pearle Europe shares

Milan, Italy—After acquiring Cole National Corp. in October, Luxottica Group SpA says its new subsidiary has sold all of its shares in Pearle Europe BV to HAL Holding NV for about $191 million.

Milan, Italy-After acquiring Cole National Corp. in October, Luxottica Group SpA says its new subsidiary has sold all of its shares in Pearle Europe BV to HAL Holding NV for about $191 million.

Luxottica officials said the sale was required by the Articles of Association of Pearle Europe in light of the acquisition. HAL owned about 19% of Cole National; the deal allows the Dutch investment company to increase its ownership of Pearle Europe to about 99%.

Pearle Europe operates more than 1,000 outlets in about 11 European countries.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.